Evidence map›Paper›PMID 34532847›Full record

ArticlePharmacological reports : PR2021

Correction to: The coming together of allosteric and phosphorylation mechanisms in the molecular integration of A2A heteroreceptor complexes in the dorsal and ventral striatal-pallidal GABA neurons.

Dasiel O Borroto-Escuela, Luca Ferraro, Sarah Beggiato, Manuel Narváez, Ramon Fores-Pons, Jose E Alvarez-Contino, Karolina Wydra, Małgorzata Frankowska, Michael Bader, Małgorzata Filip and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Pharmacological reports : PR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Dasiel O Borroto-EscuelaDepartment of Neuroscience, Karolinska Institutet, Biomedicum (B0851), Solnavagen 9, 17177, Stockholm, Sweden. dasiel.borroto.escuela@ki.se.
Luca FerraroDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Sarah BeggiatoDepartment of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, 66100, Chieti, Italy.
Manuel NarváezFacultad de Medicina, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Campus de Teatinos s/n, 29071, Málaga, Spain.
Ramon Fores-PonsFacultad de Medicina, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Campus de Teatinos s/n, 29071, Málaga, Spain.
Jose E Alvarez-ContinoFacultad de Medicina, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Campus de Teatinos s/n, 29071, Málaga, Spain.
Karolina WydraDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31343, Kraków, Poland.
Małgorzata FrankowskaDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31343, Kraków, Poland.
Michael BaderMax-Delbrück-Centrum Für Molekulare Medizin (MDC), Robert-Rössle-Strasse 10, 13125, Berlin, Germany.
Małgorzata FilipDepartment of Drug Addiction Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31343, Kraków, Poland.
Kjell FuxeDepartment of Neuroscience, Karolinska Institutet, Biomedicum (B0851), Solnavagen 9, 17177, Stockholm, Sweden. kjell.fuxe@ki.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34532847
PMCPMC8587272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.